Computational Modelling of Tunicamycin C Interaction with Potential Protein Targets: Perspectives from Inverse Docking with Molecular Dynamic Simulation

Computational Modelling of Tunicamycin C Interaction with Potential Protein Targets: Perspectives from Inverse Docking with Molecular Dynamic Simulation

Protein glycosylation plays a crucial role in cancer biology, influencing essential cellular processes such as cell signalling, immune recognition, and tumour metastasis. Therefore, this study highlights the therapeutic potential of targeting glycosylation in cancer treatment, as modulating these mo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Vivash Naidoo, Ikechukwu Achilonu, Sheefa Mirza, Rodney Hull, Jeyalakshmi Kandhavelu, Marushka Soobben, Clement Penny
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Current Issues in Molecular Biology
Subjects:	glycosylation Tunicamycin thymidine kinase 1 protein kinase A molecular dynamics therapeutic targets
Online Access:	https://www.mdpi.com/1467-3045/47/5/339
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of Genotype and Phylogenetic of Koi Herpesvirus (KHV) on Carp (Cyprinus carpio) in Lombok Island of West Nusa Tenggara Province Based on Thymidine Kinase Sequence
by: Amira Baihani, et al.
Published: (2018-02-01)

Uncovering the connection between tunicamycin-induced respiratory deficiency and reduced fluconazole tolerance in Candida glabrata
by: Lijun Zheng, et al.
Published: (2025-04-01)

Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency
by: Caterina Garone, et al.
Published: (2014-06-01)

Effect of Tunicamycin on Viability, Motility, Reactive Oxygen Species, Nitric Oxide, and Lipid Peroxidation in Boar Sperm
by: Seunghyung Lee
Published: (2025-05-01)

Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases
by: N.K. Parilova, et al.
Published: (2016-01-01)

Identification of pyrimidine metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical treatment in prostate cancer
by: Yu-Zhong Yu, et al.
Published: (2025-12-01)

Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex
by: Maria A. Colombatti Olivieri, et al.
Published: (2025-05-01)

The thymidine kinase-1 as a potential tumor marker: structure, function, activity in normal and malignant tissues
by: N. S. Sergeeva, et al.
Published: (2017-04-01)

A visualized machine learning model using noninvasive parameters to differentiate men with and without prostatic carcinoma before biopsy
by: Wenting Zhou, et al.
Published: (2025-07-01)

Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapy
by: Stefanos Ioannis Moukas, et al.
Published: (2025-03-01)

Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibition activity and molecular modelling studies
by: Mai S. El-Shoukrofy, et al.
Published: (2024-12-01)

THE THYMIDINE KINASE-1(TK-1) AS A POTENTIAL TUMOR MARKER: SERUM LEVELS IN SERUM OF PATIENTS WITH SOLID AND SYSTEM MALIGNANCE NEOPLASMS
by: N. S. Sergeeva, et al.
Published: (2017-03-01)

Infantile and early childhood onset of mitochondrial myopathy due to mutations in the TK2 gene with a phenotype of spinal muscular atrophy 5q: the first cases in Russia
by: S. A. Kurbatov, et al.
Published: (2019-11-01)

Construction of reporter vector to screen chemopreventive agents
by: WEI Wen-zhi, et al.
Published: (2007-07-01)

Thymidine Kinase 1 Expression Correlates with Tumor Aggressiveness and Metastatic Potential in OSCC
by: Chia-Jung Lee, et al.
Published: (2025-06-01)

Epigenetic suppression of creatine kinase B in adipocytes links endoplasmic reticulum stress to obesity-associated inflammation
by: Gianluca Renzi, et al.
Published: (2025-02-01)

Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches
by: Ivano Di Meo, et al.
Published: (2015-07-01)

Cyclic Peptides as Protein Kinase Modulators and Their Involvement in the Treatment of Diverse Human Diseases
by: Lorena Martínez-Alcantar, et al.
Published: (2024-12-01)

THE FACTORS THAT AFFECT STAPHYLOCCUS AUREUS CELL WALL SYNTHESIS AND RESISTANCE TO ACTINOMYCIN D
by: V. G. Bulgakova, et al.
Published: (2020-05-01)

Unveiling Palmitoyl Thymidine Derivatives as Antimicrobial/Antiviral Inhibitors: Synthesis, Molecular Docking, Dynamic Simulations, ADMET, and Assessment of Protein–Ligand Interactions
by: Sarkar M. A. Kawsar, et al.
Published: (2025-05-01)

In Silico Investigation of a New 4-Hydroxyquinolone Analogue as an Anaplastic Lymphoma Kinase (ALK) Inhibitor: Molecular Docking and ADMET Prediction
by: Yousra Ouafa Bouone, et al.
Published: (2023-11-01)

Systems Biology of Recombinant 2G12 and 353/11 mAb Production in CHO-K1 Cell Lines at Phosphoproteome Level
by: Eldi Sulaj, et al.
Published: (2025-02-01)

Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
by: Daniel Muñoz-Barba, et al.
Published: (2025-07-01)

Thymidine phosphorylase and its possible correlation with the lung cancer phenotype features
by: E. M. Bakurova, et al.
Published: (2015-04-01)

BUB1 an Overexpressed Kinase in Sarcoma: Finding New Target Therapy for Osteosarcoma, Liposarcoma, Synovial Sarcoma, and Leiomyosarcoma
by: Mercedes Olvera-Valencia, et al.
Published: (2025-07-01)

Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours
by: Chongxi Xu, et al.
Published: (2024-12-01)

Rice plants response to modulation of the ERECTA signaling
by: Yasmin Vasques Berchembrock, et al.
Published: (2025-03-01)

Editorial: Exploring novel approaches to small molecule kinase inhibitors in cancer treatment
by: Anna Carbone, et al.
Published: (2025-02-01)

Novel alloxazine analogues: design, synthesis, and antitumour efficacy enhanced by kinase screening, molecular docking, and ADME studies
by: Doaa Samaha, et al.
Published: (2024-12-01)

The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury
by: Xiaoling Zhong, et al.
Published: (2025-11-01)

Screening and identification of host signaling pathways for alleviating influenza-induced production of pro-inflammatory cytokines, IP-10, IL-8, and MCP-1, using a U937 cell-based influenza model
by: Si Chen, et al.
Published: (2025-01-01)

МOLECULAR DOCKING OF N-SUBSTITUTED DERIVATIVE OF ISOQUINOLONE WITH CATALYC DOMAIN OF PROTEIN KINASE C.
by: A. A. Gloushko, et al.
Published: (2015-09-01)

The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer
by: Faris Alrumaihi, et al.
Published: (2025-06-01)

Antagonist actions of CMK-1/CaMKI and TAX-6/calcineurin along the C. elegans thermal avoidance circuit orchestrate adaptation of nociceptive response to repeated stimuli
by: Martina Rudgalvyte, et al.
Published: (2025-04-01)

Emerging strategies and translational advancements of DDR1 in oncology
by: Yuxi Luo, et al.
Published: (2025-03-01)

Unraveling the Potential of SGK1 in Osteoporosis: From Molecular Mechanisms to Therapeutic Targets
by: Fei Yang, et al.
Published: (2025-05-01)

The diagnostic value of IL-6 and thymidine phosphorylase in the progression of osteosarcoma
by: Bushra AM Abdul Azeez, et al.
Published: (2025-04-01)

In Silico Molecular Docking of Ocimum sanctum Phytochemicals: Targeting Key Biomarkers in Oral Cancer
by: Vidhya Rekha Umapathy, et al.
Published: (2024-12-01)

An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors
by: Russell J. Schilder, et al.
Published: (2025-03-01)

Synthesis and Molecular Docking Study of 4-(3-(2-Chlorophenyl)-5-(2-Methoxyphenyl)-4,5-Dihydro-1H-Pyrazol-1-yl) Benzenesulfonamide as Antibreast Cancer Agent
by: Eka Marisa Putri, et al.
Published: (2021-12-01)